DV
Dividend Vision

TTRX — Turn Therapeutics Inc. Common Stock

Turn Therapeutics Inc. Common Stock (TTRX)

Total return is 36.7% over the past 0.8 years, 20.4 points ahead of SPY at 16.3%. Its deepest 1-year drawdown was 70.5%.

This appears to be a single-stock holding rather than a diversified ETF, representing shares of Turn Therapeutics Inc., a biotechnology company. The product lacks traditional ETF characteristics including no reported yield, distribution frequency, or expense ratio data, and carries the concentrated risk profile typical of individual equity positions rather than a diversified fund. This security would appeal primarily to investors seeking direct exposure to a specific therapeutic development company rather than those pursuing broad dividend income strategies.

TTRX key facts

Asset type
Stock
Asset class
Equity
Inception date
10/08/2025
Last close
$9.57
Market cap
$299,369,792
Average volume
98200.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.13